Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet plus low-dose vitamin D versus flexible vitamin D in recent hemodialysis patients with secondary hyperparathyroidism
2008-004558-34Phase 4Completed
- Sponsor
- Amgen
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of cinacalcet in secondary hyperparathyroidism (SHPT) and chronic kidney disease (CKD) (2 arms), sponsored by Amgen. Started Oct 2008; status: completed.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2008-004558-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004558-34.